Audiovestibular manifestations in giant cell arteritis: a prospective study.
Giant cell arteritis (GCA) is a multisystemic vasculitis of elderly people that involves large and medium-sized blood vessels with predisposition to the cranial arteries. Some cranial ischemic manifestations, in particular permanent visual loss, have been widely described. Audiovestibular manifestations have been less commonly reported. In the present study we assessed the frequency and outcome of audiovestibular manifestations in a series of GCA and isolated polymyalgia rheumatica (PMR) patients examined prospectively between June 1999 and May 2001 at the single hospital for a defined population. Patients were included in the study if a temporal artery biopsy had been performed and they were examined within a week after beginning corticosteroid treatment. Patients with abnormal otoscopy or tympanogram, history of cerebrovascular complications, syphilis, Ménière and other vestibular syndromes, infections involving the inner ear, barotrauma, or being treated with ototoxic drugs were excluded. During the study period 44 patients with GCA and 10 patients with biopsy-negative isolated PMR were examined. Patients with isolated PMR were younger. Audiovestibular dysfunction was significantly more frequent in GCA patients than in those with isolated PMR and matched controls. Almost 90% of the GCA patients had vestibular dysfunction, which was generally reversible after several days of steroid treatment; after 3 months of treatment, vestibular dysfunction was observed in only 13 (29.6%) of the 44 GCA patients. These patients with persistent vestibular dysfunction were more likely to have persistent head-shaking nystagmus. Twelve (27.3%) of the 44 GCA patients had hearing improvement after 3 months of therapy. After 6 months of therapy, only 1 of the 44 GCA patients had abnormal vestibular tests. However, no additional improvement in hearing function was observed. The present study confirms a high frequency of audiovestibular manifestations in GCA. It also suggests that audiovestibular damage may be reversible in some patients with GCA.
Amor-Dorado
Juan C
JC
Division of Otolaryngology, Hospital Xeral-Calde, Lugo, Spain. miguelaggay@hotmail.com
Llorca
Javier
J
Garcia-Porrua
Carlos
C
Costa
Carmen
C
Perez-Fernandez
Nicolas
N
Gonzalez-Gay
Miguel A
MA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D001299:Audiometry; D001706:Biopsy; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006311:Hearing Disorders / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D011111:Polymyalgia Rheumatica / Q000150:complications; D011446:Prospective Studies; D013699:Temporal Arteries / Q000473:pathology; D015837:Vestibular Diseases / Q000175:diagnosis / Q000209:etiology*; D014724:Vestibular Function Tests
D000305:Adrenal Cortex Hormones